NasdaqGM: CYTX Stock Quote
NasdaqGM: CYTX Overview
Cytori Therapeutics, Inc. develops, manufactures, and sells medical products and devices to enable the practice of regenerative medicine. The Companys technology is the Celuion family of products, which processes patients adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, enzymes, and related instrumentation. The Company also sells the StemSource family of products globally, including in the United States, for research as well as for the cryopreservation and storage of ADRCs. The other applications for the Celution System output, which are under development include, cardiovascular disease, wound healing, gastrointestinal disorders, stress urinary incontinence, liver and renal disease spinal disc degeneration and pelvic health conditions.
|
|
|||||||||||||||||||||||||||||||||||||||||
Do you know of another great research resource for CYTX that belongs here? Please let us know and provide the URL.